Advisory Services Network’s Teva Pharmaceuticals TEVA Stock Holding History

Advisory Services Network’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41M	Sell	41,526 -22,761	-35%	-$758K	0.02%	849
2026 Q1	$1.94M	Buy	64,287 +9,009	+16%	+$290K	0.03%	668
2025 Q4	$1.73M	Buy	55,278 +2,223	+4%	+$54.8K	0.02%	666
2025 Q3	$1.07M	Buy	53,055 +5,318	+11%	+$93.4K	0.02%	834
2025 Q2	$738K	Buy	47,737 +5,085	+12%	+$82.1K	0.01%	970
2025 Q1	$656K	Buy	42,652 +1,996	+5%	+$35.7K	0.01%	934
2024 Q4	$896K	Buy	40,656 +15,353	+61%	+$279K	0.02%	788
2024 Q3	$411K	Hold	25,303	–	–	0.01%	1069
2024 Q2	$411K	Sell	25,303 -18,073	-42%	-$278K	0.01%	1069
2024 Q1	$612K	Buy	43,376 +39,300	+964%	+$495K	0.01%	881
2023 Q4	$42.6K	Buy	+4,076	New	+$38.1K	﹤0.01%	2102
2023 Q2	–	Sell	-4,015	Closed	-$35.5K	–	3445
2023 Q1	$35.5K	Sell	4,015 -87	-2%	-$860	﹤0.01%	2211
2022 Q4	$37.4K	Sell	4,102 -9,013	-69%	-$78.6K	﹤0.01%	2133
2022 Q3	$106K	Buy	+13,115	New	+$116K	﹤0.01%	1277
2021 Q3	–	Sell	-2,430	Closed	-$24K	–	3044
2021 Q2	$24K	Buy	+2,430	New	+$25.7K	﹤0.01%	2427
2021 Q1	–	Sell	-1,984	Closed	-$19K	–	2785
2020 Q4	$19K	Sell	1,984 -724	-27%	-$6.94K	﹤0.01%	2175
2020 Q3	$25K	Buy	+2,708	New	+$28.6K	﹤0.01%	1977
2020 Q2	–	Sell	-4,073	Closed	-$36K	–	2572
2020 Q1	$36K	Sell	4,073 -157	-4%	-$1.61K	﹤0.01%	1548
2019 Q4	$41K	Buy	4,230 +2,729	+182%	+$24.4K	﹤0.01%	1605
2019 Q3	$14K	Hold	1,501	–	–	﹤0.01%	2013
2019 Q2	$14K	Sell	1,501 -2,117	-59%	-$25.5K	﹤0.01%	2011
2019 Q1	$57K	Sell	3,618 -6,750	-65%	-$119K	﹤0.01%	1197
2018 Q4	$160K	Sell	10,368 -18,574	-64%	-$381K	0.01%	768
2018 Q3	$623K	Buy	28,942 +23,791	+462%	+$552K	0.05%	467
2018 Q2	$122K	Buy	5,151 +281	+6%	+$5.73K	0.01%	873
2018 Q1	$83K	Buy	4,870 +2,639	+118%	+$51.5K	0.01%	1105
2017 Q4	$42K	Sell	2,231 -210	-9%	-$3.16K	﹤0.01%	1357
2017 Q3	$43K	Buy	2,441 +701	+40%	+$15.8K	﹤0.01%	1159
2017 Q2	$58K	Sell	1,740 -3,339	-66%	-$103K	0.01%	1011
2017 Q1	$163K	Buy	+5,079	New	+$173K	0.02%	671
2016 Q3	$365K	Buy	7,928 +356	+5%	+$18.6K	0.07%	375
2016 Q2	$380K	Buy	7,572 +301	+4%	+$16K	0.09%	313
2016 Q1	$389K	Buy	7,271 +1,742	+32%	+$102K	0.11%	239
2015 Q4	$363K	Buy	5,529 +612	+12%	+$37.8K	0.12%	220
2015 Q3	$278K	Sell	4,917 -98	-2%	-$6.35K	0.08%	238
2015 Q2	$305K	Buy	5,015 +706	+16%	+$43.6K	0.09%	238
2015 Q1	$278K	Sell	4,309 -148	-3%	-$8.61K	0.08%	243
2014 Q4	$260K	Buy	4,457 +355	+9%	+$19.8K	0.08%	219
2014 Q3	$220K	Sell	4,102 -11,122	-73%	-$589K	0.08%	244
2014 Q2	$798K	Buy	15,224 +380	+3%	+$19.4K	0.34%	83
2014 Q1	$784K	Buy	14,844 +12,543	+545%	+$580K	0.4%	68
2013 Q4	$92K	Buy	+2,301	New	+$90.6K	0.05%	254

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Advisory Services Network's TEVA Position: Q2 2026 in Review

Advisory Services Network reduced its Teva Pharmaceuticals (TEVA) stake by 35% in Q2 2026, selling an estimated $758K and leaving 41,526 shares worth $1.41M. The position accounts for 0.02% of the portfolio, ranked #849.

Advisory Services Network first reported a position in TEVA in Q4 2013 and has held it in 42 quarters since. The position peaked at $1.94M in Q1 2026. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Advisory Services Network held 41,526 shares of Teva Pharmaceuticals worth $1.41M as of Q2 2026.
Advisory Services Network sold 22,761 Teva Pharmaceuticals shares in Q2 2026, an estimated $758K.
Teva Pharmaceuticals made up 0.02% of Advisory Services Network's portfolio in Q2 2026, its #849 holding.
Advisory Services Network first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 42 quarters since.
Advisory Services Network's Teva Pharmaceuticals position peaked at $1.94M in Q1 2026.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.